Physician profile
Aleksandr Plotkin
NPI 1467546945
$435.35
in general payments reported to CMS, 2019-2025
12 companies · $43.85 in 2025
The $43.85 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.39 · 2020: $51.18 · 2021: $174 · 2022: $38.42 · 2024: $64.89 · 2025: $43.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $108.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $84.35 | 2020-2024 | Mounjaro, Zepbound |
| Novo Nordisk INC | $79.41 | 2019-2025 | |
| Abbvie INC. | $48.68 | 2022-2024 | |
| Nestle Healthcare Nutrition INC. | $43.75 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $30.66 | 2021 | |
| Merck Sharp & Dohme LLC | $26.37 | 2019 | |
| Vivus LLC | $20.00 | 2021 | |
| Xeris Pharmaceuticals, INC. | $19.05 | 2025 | Gvoke Hypopen |
| Heartflow, INC. | $17.67 | 2024 | |
| Nevro Corp. | $16.82 | 2022 | |
| Allergan, INC. | $13.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aleksandr Plotkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.